{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:58:56Z","timestamp":1769835536704,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclooxygenase-2 inhibitors (coxibs) are characterized by multiple molecular off-target effects and increased coronary artery disease (CAD) risk. Here, we systematically explored common variants of genes representing molecular targets of coxibs for association with CAD. Given a broad spectrum of pleiotropic effects of coxibs, our intention was to narrow potential mechanisms affecting CAD risk as we hypothesized that the affected genes may also display genomic signals of coronary disease risk. A Drug Gene Interaction Database search identified 47 gene products to be affected by coxibs. We traced association signals in 200-kb regions surrounding these genes in 84,813 CAD cases and 202,543 controls. Based on a threshold of 1\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup> (Bonferroni correction for 3131 haplotype blocks), four gene loci yielded significant associations. The lead SNPs were rs7270354 (MMP9), rs4888383 (BCAR1), rs6905288 (VEGFA1), and rs556321 (CACNA1E). By additional genotyping, rs7270354 at MMP9 and rs4888383 at BCAR1 also reached the established GWAS threshold for genome-wide significance. The findings demonstrate overlap of genes affected by coxibs and those mediating CAD risk and points to further mechanisms, which are potentially responsible for coxib-associated CAD risk. The novel approach furthermore suggests that genetic studies may be useful to explore the clinical relevance of off-target drug effects.<\/jats:p>","DOI":"10.1038\/s41598-017-10928-4","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T14:00:58Z","timestamp":1503669658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-0326","authenticated-orcid":false,"given":"Ingrid","family":"Br\u00e6nne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Willenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"Tragante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Reiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Kleinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"von Ameln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristen J.","family":"Willer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp S.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veikko","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meitinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh J.","family":"Samani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-8669","authenticated-orcid":false,"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-6231","authenticated-orcid":false,"given":"Jeanette","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"10928_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","volume":"37","author":"M Schmidt","year":"2016","unstructured":"Schmidt, M. et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J \n                           37, 1015\u20131023, doi:10.1093\/eurheartj\/ehv505 (2016).","journal-title":"Eur Heart J"},{"key":"10928_CR2","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman, E. M. et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation \n                           115, 1634\u20131642, doi:10.1161\/CIRCULATIONAHA.106.181424 (2007).","journal-title":"Circulation"},{"key":"10928_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1126\/science.1224398","volume":"336","author":"CP Cannon","year":"2012","unstructured":"Cannon, C. P. & Cannon, P. J. Physiology. COX-2 inhibitors and cardiovascular risk. Science \n                           336, 1386\u20131387, doi:10.1126\/science.1224398 (2012).","journal-title":"COX-2 inhibitors and cardiovascular risk. Science"},{"key":"10928_CR4","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen, S. E. et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med \n                           375, 2519\u20132529, doi:10.1056\/NEJMoa1611593 (2016).","journal-title":"N Engl J Med"},{"key":"10928_CR5","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1056\/NEJMe1614257","volume":"375","author":"DT Felson","year":"2016","unstructured":"Felson, D. T. Safety of Nonsteroidal Antiinflammatory Drugs. N Engl J Med \n                           375, 2595\u20132596, doi:10.1056\/NEJMe1614257 (2016).","journal-title":"N Engl J Med"},{"key":"10928_CR6","doi-asserted-by":"publisher","unstructured":"Nurmohamed, M. T. Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen. Nat Rev Rheumatol, doi:10.1038\/nrrheum.2017.4 (2017).","DOI":"10.1038\/nrrheum.2017.4"},{"key":"10928_CR7","doi-asserted-by":"publisher","unstructured":"CARDIoGRAMplusC4D-Consortium et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45, 25\u201333, doi:10.1038\/ng.2480 (2013).","DOI":"10.1038\/ng.2480"},{"key":"10928_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet \n                           34, 154\u2013156, doi:10.1038\/ng1161 (2003).","journal-title":"Nat Genet"},{"key":"10928_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","volume":"371","author":"Tg","year":"2014","unstructured":"Tg et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med \n                           371, 22\u201331, doi:10.1056\/NEJMoa1307095 (2014).","journal-title":"N Engl J Med"},{"key":"10928_CR10","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/eurheartj\/ehv153","volume":"36","author":"H Schunkert","year":"2015","unstructured":"Schunkert, H. Brotherhood of genetics and preventive medication. Eur Heart J \n                           36, 1566\u20131568, doi:10.1093\/eurheartj\/ehv153 (2015).","journal-title":"Eur Heart J"},{"key":"10928_CR11","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/eurheartj\/ehu168","volume":"35","author":"S Ross","year":"2014","unstructured":"Ross, S. et al. Association of cyclooxygenase-2 genetic variant with cardiovascular disease. Eur Heart J \n                           35, 2242\u20132248a, doi:10.1093\/eurheartj\/ehu168 (2014).","journal-title":"Eur Heart J"},{"key":"10928_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nmeth.2689","volume":"10","author":"M Griffith","year":"2013","unstructured":"Griffith, M. et al. DGIdb: mining the druggable genome. Nat Methods \n                           10, 1209\u20131210, doi:10.1038\/nmeth.2689 (2013).","journal-title":"Nat Methods"},{"key":"10928_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3396","author":"CAD Consortium","year":"2015","unstructured":"Consortium, C. A. D. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. doi:10.1038\/ng.3396 (2015).","journal-title":"Nat Genet"},{"key":"10928_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet \n                           43, 333\u2013338, doi:10.1038\/ng.784 (2011).","journal-title":"Nat Genet"},{"key":"10928_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/EDE.0b013e31828b2cbb","volume":"24","author":"BM Psaty","year":"2013","unstructured":"Psaty, B. M. & Sitlani, C. The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium as a model of collaborative science. Epidemiology \n                           24, 346\u2013348, doi:10.1097\/EDE.0b013e31828b2cbb (2013).","journal-title":"Epidemiology"},{"key":"10928_CR16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1142842","volume":"316","author":"A Helgadottir","year":"2007","unstructured":"Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science \n                           316, 1491\u20131493, doi:10.1126\/science.1142842 (2007).","journal-title":"Science"},{"key":"10928_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2010.93","volume":"6","author":"M Inouye","year":"2010","unstructured":"Inouye, M. et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol \n                           6, 441, doi:10.1038\/msb.2010.93 (2010).","journal-title":"Mol Syst Biol"},{"key":"10928_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2337\/db10-0933","volume":"60","author":"F Renstrom","year":"2011","unstructured":"Renstrom, F. et al. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes \n                           60, 345\u2013354, doi:10.2337\/db10-0933 (2011).","journal-title":"Diabetes"},{"key":"10928_CR19","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2337\/db08-1607","volume":"58","author":"A Stancakova","year":"2009","unstructured":"Stancakova, A. et al. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes \n                           58, 1212\u20131221, doi:10.2337\/db08-1607 (2009).","journal-title":"Diabetes"},{"key":"10928_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ije\/dyh327","volume":"34","author":"A Evans","year":"2005","unstructured":"Evans, A. et al. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol \n                           34, 21\u201327, doi:10.1093\/ije\/dyh327 (2005).","journal-title":"Int J Epidemiol"},{"key":"10928_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.107.730614","volume":"117","author":"H Schunkert","year":"2008","unstructured":"Schunkert, H. et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation \n                           117, 1675\u20131684, doi:10.1161\/CIRCULATIONAHA.107.730614 (2008).","journal-title":"Circulation"},{"key":"10928_CR22","first-page":"143","volume":"60","author":"Y Hong","year":"1997","unstructured":"Hong, Y., Pedersen, N. L., Brismar, K. & de Faire, U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet \n                           60, 143\u2013152 (1997).","journal-title":"Am J Hum Genet"},{"key":"10928_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1086\/383251","volume":"74","author":"DR Nyholt","year":"2004","unstructured":"Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet \n                           74, 765\u2013769, doi:10.1086\/383251 (2004).","journal-title":"Am J Hum Genet"},{"key":"10928_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials \n                           7, 177\u2013188 (1986).","journal-title":"Control Clin Trials"},{"key":"10928_CR25","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gkr917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res \n                           40, D930\u2013934, doi:10.1093\/nar\/gkr917 (2012).","journal-title":"Nucleic Acids Res"},{"key":"10928_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002367","volume":"7","author":"M Rotival","year":"2011","unstructured":"Rotival, M. et al. Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet \n                           7, e1002367, doi:10.1371\/journal.pgen.1002367 (2011).","journal-title":"PLoS Genet"},{"key":"10928_CR27","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.2756","volume":"45","author":"HJ Westra","year":"2013","unstructured":"Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet \n                           45, 1238\u20131243, doi:10.1038\/ng.2756 (2013).","journal-title":"Nat Genet"},{"key":"10928_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"GT Consortium","year":"2015","unstructured":"Consortium, G. T. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science \n                           348, 648\u2013660, doi:10.1126\/science.1262110 (2015).","journal-title":"Science"},{"key":"10928_CR29","doi-asserted-by":"publisher","first-page":"i185","DOI":"10.1093\/bioinformatics\/btu273","volume":"30","author":"R Leslie","year":"2014","unstructured":"Leslie, R., O\u2019Donnell, C. J. & Johnson, A. D. GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database. Bioinformatics \n                           30, i185\u2013194, doi:10.1093\/bioinformatics\/btu273 (2014).","journal-title":"Bioinformatics"},{"key":"10928_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics \n                           27, 1739\u20131740, doi:10.1093\/bioinformatics\/btr260 (2011).","journal-title":"Bioinformatics"},{"key":"10928_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ajhg.2017.01.027","volume":"100","author":"M Civelek","year":"2017","unstructured":"Civelek, M. et al. Genetic Regulation of Adipose Gene Expression and Cardio-Metabolic Traits. Am J Hum Genet \n                           100, 428\u2013443, doi:10.1016\/j.ajhg.2017.01.027 (2017).","journal-title":"Am J Hum Genet"},{"key":"10928_CR32","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1161\/ATVBAHA.115.306108","volume":"35","author":"I Braenne","year":"2015","unstructured":"Braenne, I. et al. Prediction of Causal Candidate Genes in Coronary Artery Disease Loci. Arterioscler Thromb Vasc Biol \n                           35, 2207\u20132217, doi:10.1161\/ATVBAHA.115.306108 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10928_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jim-51-05-17","volume":"51","author":"P Ferroni","year":"2003","unstructured":"Ferroni, P. et al. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. J Investig Med \n                           51, 295\u2013300 (2003).","journal-title":"J Investig Med"},{"key":"10928_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben, A. et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev \n                           56, 549\u2013580, doi:10.1124\/pr.56.4.3 (2004).","journal-title":"Pharmacol Rev"},{"key":"10928_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/HYPERTENSIONAHA.109.132274","volume":"54","author":"JP Granger","year":"2009","unstructured":"Granger, J. P. Vascular endothelial growth factor inhibitors and hypertension: a central role for the kidney and endothelial factors? Hypertension \n                           54, 465\u2013467, doi:10.1161\/HYPERTENSIONAHA.109.132274 (2009).","journal-title":"Hypertension"},{"key":"10928_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","volume":"100","author":"K Hayashi","year":"2007","unstructured":"Hayashi, K. et al. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res \n                           100, 342\u2013353, doi:10.1161\/01.RES.0000256155.31133.49 (2007).","journal-title":"Circ Res"},{"key":"10928_CR37","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-03-1945","volume":"64","author":"D Wei","year":"2004","unstructured":"Wei, D. et al. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res \n                           64, 2030\u20132038 (2004).","journal-title":"Cancer Res"},{"key":"10928_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jacc.2006.09.053","volume":"49","author":"S Yla-Herttuala","year":"2007","unstructured":"Yla-Herttuala, S., Rissanen, T. T., Vajanto, I. & Hartikainen, J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol \n                           49, 1015\u20131026, doi:10.1016\/j.jacc.2006.09.053 (2007).","journal-title":"J Am Coll Cardiol"},{"key":"10928_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.111.00841","volume":"61","author":"AM Thijs","year":"2013","unstructured":"Thijs, A. M. et al. Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans. Hypertension \n                           61, 1060\u20131065, doi:10.1161\/HYPERTENSIONAHA.111.00841 (2013).","journal-title":"Hypertension"},{"key":"10928_CR40","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1073\/pnas.0813306106","volume":"106","author":"M Hu","year":"2009","unstructured":"Hu, M. et al. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA \n                           106, 3372\u20133377, doi:10.1073\/pnas.0813306106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"10928_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer \n                           2, 161\u2013174, doi:10.1038\/nrc745 (2002).","journal-title":"Nat Rev Cancer"},{"key":"10928_CR42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1089\/dna.2014.2511","volume":"33","author":"SS Yadav","year":"2014","unstructured":"Yadav, S. S. et al. High serum level of matrix metalloproteinase 9 and promoter polymorphism \u2212 1562 C:T as a new risk factor for metabolic syndrome. DNA Cell Biol \n                           33, 816\u2013822, doi:10.1089\/dna.2014.2511 (2014).","journal-title":"DNA Cell Biol"},{"key":"10928_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000151373.33830.41","volume":"25","author":"Yasmin","year":"2005","unstructured":"Yasmin et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol \n                           25, 372, doi:10.1161\/01.ATV.0000151373.33830.41 (2005).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10928_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI25074","volume":"116","author":"PJ Gough","year":"2006","unstructured":"Gough, P. J., Gomez, I. G., Wille, P. T. & Raines, E. W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest \n                           116, 59\u201369, doi:10.1172\/JCI25074 (2006).","journal-title":"J Clin Invest"},{"key":"10928_CR45","doi-asserted-by":"crossref","unstructured":"Ichikawa, Y., Yokoyama, U. & Ishikawa, Y. Prostaglandin E2 receptor EP4 signaling in vascular smooth muscle cells decreases aortic elasticity (1123.2). The FASEB Journal \n                           28 (2014).","DOI":"10.1096\/fasebj.28.1_supplement.1123.2"},{"key":"10928_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00018-009-0213-1","volume":"67","author":"N Tikhmyanova","year":"2010","unstructured":"Tikhmyanova, N., Little, J. L. & Golemis, E. A. CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci \n                           67, 1025\u20131048, doi:10.1007\/s00018-009-0213-1 (2010).","journal-title":"Cell Mol Life Sci"},{"key":"10928_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/jnci\/92.2.112","volume":"92","author":"A Brinkman","year":"2000","unstructured":"Brinkman, A., van der Flier, S., Kok, E. M. & Dorssers, L. C. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells. J Natl Cancer Inst \n                           92, 112\u2013120 (2000).","journal-title":"J Natl Cancer Inst"},{"key":"10928_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1124\/mol.65.4.832","volume":"65","author":"M Kyaw","year":"2004","unstructured":"Kyaw, M. et al. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1\/2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol \n                           65, 832\u2013841, doi:10.1124\/mol.65.4.832 (2004).","journal-title":"Mol Pharmacol"},{"key":"10928_CR49","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/me.2004-0536","volume":"20","author":"L Hunyady","year":"2006","unstructured":"Hunyady, L. & Catt, K. J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol \n                           20, 953\u2013970, doi:10.1210\/me.2004-0536 (2006).","journal-title":"Mol Endocrinol"},{"key":"10928_CR50","first-page":"15","volume":"2","author":"LI Brueggemann","year":"2010","unstructured":"Brueggemann, L. I., Mani, B. K., Mackie, A. R., Cribbs, L. L. & Byron, K. L. Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications. Mol Cell Pharmacol \n                           2, 15\u201319 (2010).","journal-title":"Mol Cell Pharmacol"},{"key":"10928_CR51","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall, W. A., Perez-Reyes, E., Snutch, T. P. & Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev \n                           57, 411\u2013425, doi:10.1124\/pr.57.4.5 (2005).","journal-title":"Pharmacol Rev"},{"key":"10928_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/FPC.0b013e32834f94cb","volume":"22","author":"L Gong","year":"2012","unstructured":"Gong, L. et al. Celecoxib pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics \n                           22, 310\u2013318, doi:10.1097\/FPC.0b013e32834f94cb (2012).","journal-title":"Pharmacogenet Genomics"},{"key":"10928_CR53","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics \n                           26, 2336\u20132337, doi:10.1093\/bioinformatics\/btq419 (2010).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10928-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:03:05Z","timestamp":1671789785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10928-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10928-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10252"}}